Roles of MLL histone methyalses in estrogen mediated regulation of HDLR-SRB1
Roles of MLL histone methyalses in estrogen mediated regulation of HDLR-SRB1
批准号:
7882188
负责人:
Subhrangsu S Mandal
金额:
$21.9万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-01 至 2010-04-02
关键词:
Alternative SplicingBindingBiochemicalBloodBone DevelopmentCardiovascular DiseasesCardiovascular PhysiologyCardiovascular systemCell Cycle RegulationCell LineCellsCholesterolCholesterol HomeostasisCollaborationsComplexDecision MakingDiseaseEnvironmentEnzymesEpigenetic ProcessEstradiolEstrogen ReceptorsEstrogensGene ExpressionGene Expression RegulationGenesGenetic TranscriptionHistone H3HistonesHormonalHormonesHumanLaboratoriesLinkLysineMLL2 geneMalignant NeoplasmsMediatingNuclear Hormone ReceptorsPlayProcessProtein FamilyProteinsRNA SplicingRegulationRoleSignal TransductionTestingTissuesTranscription Factor AP-1Transcriptional ActivationTransferaseVariantbasebiological adaptation to stresscancer therapyestrophilinexperiencehigh density lipoprotein receptorhistone methyltransferaseknock-downleukemiamRNA Precursormembernovelpromoterpublic health relevancereproductiveresearch studyscavenger receptortranscription factoruptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The estrogen receptors (ERs) are key players in estrogen signaling. In addition to their crucial roles in mediating hormonal effects in reproductive tissues, ERs play important roles in bone development, normal cardiovascular functions, cardiovascular disease (CVD), and in cancer. ER mediated gene regulation and signaling is a complex process which involves many transcription factors and coregulators. Mixed Lineage Leukemias (MLLs) are human histone methyl-transferases that play critical roles in gene expression, epigenetics, and cancer. In human, there are several MLL families of proteins such as MLL1, MLL2, MLL3, MLL4, etc. Recent studies demonstrated that several MLLs act as coactivators for ER in regulation of estrogen responsive genes. Although, the importance of MLLs in gene expression, hormone signaling, and disease is well recognized their mechanism of actions and any roles associated with CVD are largely unknown. Our preliminary studies demonstrated that human HDLR-SRB1 (high density lipoprotein receptor scavenger receptor type B1, or SRB1), a protein that is critical for maintaining blood cholesterol, is transcriptionally activated by estrogen. Estrogen also induced differential splicing of SRB1 pre-mRNA. Interestingly, knock down of either MLL1 or MLL2 down regulated the estrogen mediated activation of SRB1 and also modulated the alternative splicing of SRB1 variants, suggesting their critical roles in these processes. Importantly, knock down of MLL1 and MLL2 also significantly decreased the cholesterol uptake efficiencies of steroidogenic cells indicating their critical roles in cholesterol uptake. Herein, experiments are proposed to elucidate the biochemical roles of different MLL histone methylases and their collaboration with ERs in estrogen mediated activation and alternate splicing of HDLR-SRB1 and related genes. Experiments are also proposed to understand the roles of MLLs and ERs in cholesterol transport in steroidogenic cells. These studies will reveal novel functions of MLL histone methylating enzymes in estrogen signaling, cholesterol transport and hence in CVD. Furthermore, as estrogen signaling is closely associated with cancer and cardiovascular disease, these studies will advance our understanding about these diseases and eventually will open up new avenues for cardiovascular and cancer therapy. 1
PUBLIC HEALTH RELEVANCE: The estrogen receptors (ERs) are key players in mediating hormonal effects in reproductive tissues, in bone development, and in diseases including cardiovascular disease (CVD) and cancer. Herein experiments are proposed to understand the biochemical mechanism of estrogen signaling associated with cholesterol homeostasis. Completion of these studies will advance our understanding about CVD and cancer and will open up new avenues for potential therapy. 1
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IDO1 regulation of SR-BI and cholesterol homeostasis in macrophages
-
批准号:10731003
-
项目类别:
-
资助金额:$45.75万
-
财政年份:2023
-
负责人:Subhrangsu S Mandal
-
依托单位:
Endocrine Disruptors: Assessment of endocrine disruption activity, mechanism and
-
批准号:7940433
-
项目类别:
-
资助金额:$44.49万
-
财政年份:2010
-
负责人:Subhrangsu S Mandal
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: